Search News
| 86.33 BATS BZX Real-Time Price As of 12:59pm ET |  -0.12 / -0.14%Today’s Change | 66.66 Today|||52-Week Range 97.98 | +1.72% Year-to-Date |
The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
| Why These Small Cap Biotech ETFs are Soaring Apr 18 / Zacks.com - Paid Partner Content | Is PowerShares Dynamic Biotechnology & Genome Portfolio (PBE) a Hot ETF Right Now? Apr 12 / Zacks.com - Paid Partner Content |
| 1 month | -2.42% | 3 years | +3.83% | |
| 3 months | -8.38% | 5 years | +20.49% | |
| 1 year | +25.13% | Since inception | +14.89% |
| Previous close | $86.45 |
| Open day’s range | 85.07 – 87.22 |
| Net asset value (NAV) | 86.37 (04/24/2018) |
| Daily volume | 383,980 |
| Average volume (3 months) | 4,855,499 |
| XBI | Category | |
|---|---|---|
| Performance 5-yr return | +20.49% | +14.29% |
| Expense Gross exp ratio | 0.35% | 1.30% |
| Risk 5 year sharpe ratio | 0.79 | 0.92 |
| Net assets | $4.9B | $3.0B |
| Average market cap | $3.2B | $10.0B |
| Average P/E | -- | 22.2 |
| Dividend / Share | -- | 0.30% |
| XLV Health Care Select Sector SPDR® Fund |
| FHLC Fidelity® MSCI Health Care Index ETF |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| Healthcare | 100.00% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
| ONCE Spark Therapeutics Inc | 1.63% |
| RDUS Radius Health Inc | 1.53% |
| REGN Regeneron Pharmaceuticals | 1.52% |
| FOLD Amicus Therapeutics Inc | 1.52% |
| SRPT Sarepta Therapeutics Inc | 1.50% |
| ALKS Alkermes Plc | 1.49% |
| AGIO Agios Pharmaceuticals Inc | 1.47% |
| UTHR United Therapeutics Corp | 1.47% |
| BMRN Biomarin Pharmaceutical Inc | 1.46% |
| CELG Celgene | 1.45% |
